Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Bio-Rad Laboratories, Inc.Class A (BIO) has a market cap of $7.89B with year-over-year revenue growth of +0.7%. Net margin stands at 29.4%. The stock trades at a P/E ratio of 10.4.
Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, BIO posted revenue growth of +0.7% and trades at a P/E of 10.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.